IDEAYA announces first patient dosing of IDE196 for solid tumors outside of uveal melanoma

This article was originally published here

IDEAYA previously announced initiation of this Phase 1/2 clinical trial evaluating IDE196 in a tissue-type agnostic basket trial for treatment of metastatic uveal melanoma and other solid tumors

The post IDEAYA announces first patient dosing of IDE196 for solid tumors outside of uveal melanoma appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply